Cathy Eng, VICC Associate Director, Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, posted on X:
“Thanks to all that showed up for our multi-D rectal cancer session at ESMO GI25.
GREAT discussion with Drs. Prager, Garcia-Aguilar and Vendrely.”
Further Reading: ESMO GI 2025 Highlights: PANOVA-3 Trial on TTFields + GnP in Unresectable LAPC
